SS Innovations International, Inc. (NASDAQ: SSII) announced the successful completion of what it describes as the world's longest-distance robotic cardiac telesurgery, a procedure performed across approximately 12,500 miles of fiber network between Guyana and India. The operation, conducted remotely by CEO and cardiac surgeon Dr. Sudhir Srivastava from Guyana, utilized the company's SSi Mantra surgical robotic system on the patient side in India, with network latency measured at approximately 290-300 milliseconds.
This achievement surpasses SS Innovations' previous telesurgery distance record of about 6,250 miles and further demonstrates the capabilities of the SSi Mantra platform in long-distance surgical applications. The milestone coincides with the launch of Guyana's National Robotic Surgery Program and follows regulatory approval for the SSi Mantra in Guyana. According to the company, 173 telesurgeries have now been performed using the platform globally, including 22 cardiac telesurgeries, making SSi Mantra the only surgical robotic system currently used for robotic cardiac telesurgery.
The implications of this record-breaking telesurgery are significant for the future of global healthcare. By enabling expert surgeons to perform complex procedures remotely, the technology has the potential to bridge geographical gaps in access to specialized surgical care, particularly in underserved regions. The 12,500-mile distance demonstrates that latency challenges can be managed effectively, opening the door for telesurgery to become a routine option in remote areas, disaster zones, or even space missions. For patients in Guyana and similar locations, this could mean access to world-class cardiac surgery without the need for travel, reducing costs and risks associated with medical tourism.
For the healthcare industry, the achievement underscores the growing viability of robotic telesurgery as a tool for collaboration and training. Surgeons in different parts of the world can share expertise in real time, potentially accelerating the adoption of minimally invasive techniques. However, widespread implementation will require investment in robust fiber-optic infrastructure and regulatory frameworks to ensure safety and liability coverage.
SS Innovations develops surgical robotic technologies with a vision to make robotic surgery affordable and accessible globally. Its product range includes the SSi Mantra surgical robotic system and the SSi Mudra surgical instruments, which support various procedures including cardiac surgery. The company plans to expand the global presence of its solutions. For more information, visit the company's website at https://ssinnovations.com/.
This news matters because it represents a leap forward in telemedicine capabilities, demonstrating that distance is no longer a barrier to receiving expert surgical care. As the technology matures, it could transform healthcare delivery, making specialized procedures accessible to populations currently lacking such services. The successful completion of this record-setting telesurgery highlights the potential for robotic systems to overcome geographical limitations and improve patient outcomes worldwide.
